Orthofix International (OFIX) Misses Q3 EPS by 36c, reiterates guidance
Get Alerts OFIX Hot Sheet
Price: $9.29 -0.21%
EPS Growth %: +52.6%
Financial Fact:
Nonoperating Income (Expense), Total: -163K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +52.6%
Financial Fact:
Nonoperating Income (Expense), Total: -163K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Orthofix International (NASDAQ: OFIX) reported Q3 EPS of ($0.71), $0.36 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $196.6 million versus the consensus estimate of $196.52 million.
GUIDANCE:
Orthofix International sees FY2024 revenue of $795-800 million, versus the consensus of $797 million. Non-GAAP adjusted EBITDA is expected to range from $64 million to $69 million.
The Company expects to continue to be free cash flow positive for the remainder of 2024.
For earnings history and earnings-related data on Orthofix International (OFIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
- Canaccord Starts Kistos Holdings (KIST:LN) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share